Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

The GHTC this week released a new fact sheet on the US Agency for International Development and its longstanding support for global health product development.

Despite the recent federal budget deal that re-opened the government, the “worst may not be over for US researchers,” Nature reports. Researchers “face the possibility of another government shutdown in mid-January, when the deeply divided US Congress must agree on a new plan to fund government operations.”

For the first time, an oral cholera vaccine has shown sustained protection for five years against the disease.

GHTC member Aeras has released its 2012 annual report, which highlights progress made toward developing safe and effective vaccines against tuberculosis.

A new study in The Lancet Global Health provides an in-depth assessment of the drug and vaccine landscape for neglected diseases between 2000 and 2011.

Health ministers of countries represented in the Organization of the Islamic Conference (OIC) have agreed to appoint Indonesia as the “center of excellence” in developing vaccines that would be supplied to OIC member states.

A new Q&A with Renate Baehr—executive director of the German organization Deutsche Stiftung Weltbevoelkerung—highlights the importance of public-private partnerships for global health.